Intraplatelet signaling mechanisms of the priming effect of matrix metalloproteinase-2 on platelet aggregation

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 11, 2005, Pages 2526-2535

  Falcinelli, E ^a   Guglielmini, G ^a   Torti, M ^b   Gresele, Paolo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Matrix metalloproteinases; PI3 K; Platelets; Priming; Signal transduction

Indexed keywords

GELATINASE A; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PLECKSTRIN; PROSTAGLANDIN SYNTHASE INHIBITOR; WORTMANNIN;

ARTICLE; CALCIUM TRANSPORT; ENZYME DEGRADATION; EXTRACELLULAR MATRIX; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; BLOOD PLATELETS; CALCIUM; CHROMONES; DRUG SYNERGISM; ESTRENES; HUMANS; INDOLES; INOSITOL 1,4,5-TRISPHOSPHATE; MATRIX METALLOPROTEINASE 2; MORPHOLINES; PHOSPHOLIPASE C; PLATELET AGGREGATION; PROTEIN KINASE C; PYRROLIDINONES; RECOMBINANT PROTEINS; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION; THROMBIN; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 28444487916     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01614.x     Document Type: Article

References (47)

1. Massova I, Kotra LP, Fridman R, Mobashery S. Matrix metalloproteinases: structures, evolution, and diversification. FASEB J 1998; 12: 1075-95.
2. Kuzuya M, Iguchi A. Role of metalloproteinases in vascular remodelling. J Atheroscler Thromb 2003; 10: 275-82.
3. Shah PK, Galis ZS. Matrix metalloproteinase hypothesis of plaque rupture: players keep piling up but questions remain. Circulation 2001; 104: 1878-80.
4. Ferrans VJ. New insights into the world of matrix metalloproteinases. Circulation 2002; 105: 405-7.
5. Galis ZS, Khatri JI. Matrix metalloproteinases in vascular remodeling and atherogenesis. Circ Res 2002; 90: 251-62.
6. Sawicki G, Salas E, Murat J, Miszta-Lane H, Radomski M-W. Release of gelatinase A during platelet aggregation. Nature 1997; 386: 616-8.
7. Fernandez-Patron C, Martinez-Cuesta MA, Salas E, Sawicki G, Wozniak M, Radomski MW, Davidge ST. Differential regulation of platelet aggregation by matrix metalloproteinase 9 and 2. Thromb Haemost 1999; 82: 1730-5.
8. Galt SW, Lindemann S, Allen L, Medd DJ, Falk JM, McIntyre TM, Prescott SM, Kraiss LW, Zimmerman GA, Weyrich AS. Outside-in signals delivered by matrix metalloproteinase-1 regulate platelet function. Circ Res 2002; 90: 1093-9.
9. Kazes I, Elalamy I, Sraer JD, Hatmi M, Nguyen G. Platelet release of trimolecular complex components MT1-MMP/TIMP-2/MMP-2: involvement in MMP-2 activation and platelet aggregation. Blood 2000; 96: 3064-9.
10. Kowalska MA, Juliano D, Trybulec M, Lu W, Niewiarowski S. Zinc ions potentiate adenosine diphosphate-induced platelet aggregation by activation of protein kinase C. J Lab Clin Med 1994; 123: 102-9.
11. Vezza R, Roberti R, Nenci GG, Gresele P. Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C. Blood 1993; 82: 2704-13.
12. Nakata M, Yada T, Soejima N, Maruyama I. Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes 1999; 48: 426-9.
13. Pasquet JM, Gross BS, Gratacap MP, Quek L, Pasquet S, Payrastre B, van Willigen G, Mountford JC, Watson SP. Thrombopoietin potentiates collagen receptor signaling in platelets through a phosphatidylinositol 3-kinase-dependent pathway. Blood 2000; 95: 3429-34.
14. De Candia E, Hall SW, Rutella S, Landolfi R, Andress RK, De Cristofaro R. Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of PAR-1 on intact platelets. J Biol Chem 2001; 276: 4692-8.
15. Cattaneo M. The platelet P2Y receptors as target for new antithrombotic drugs. J Thromb Haemost 2003; 1: 1133-5.
16. Fridman R, Bird RE, Hoyhtya M, Oelkuct M, Komarek D, Liang CM, Liotta LA, Stetler-Stevenson WG, Fuerst TR. Expression of human recombinant 72 kDa gelatinase and tissue inhibitor of metalloproteinase-2 (TIMP-2): characterization of complex and free enzyme. Biochem J 1993; 289: 411-6.
17. Bergmann U, Tuuttila A, Stetler-Stevenson W-G, Tryggvason K. Autolytic activation of recombinant human 72 kDa type IV collagenase. Biochemistry 1995; 64: 2819-25.
18. Mustard JF, Perry DW, Ardly NG, Packham MA. Preparation of suspension of washed platelets from humans. Br J Haematol 1972; 22: 193-204.
19. Stasi M, Gresele P, Porcellati S, Quero E, Nenci GG, Goracci G. Activation of phospholipase A2 and β-thromboglobulin release in human platelets: comparative effects of thrombin and fluoroaluminate. Biochim Biophys Acta 1992; 1124: 279-87.
20. Pulcinelli F, Gresele P, Bonuglia M, Gazzaniga P. Evidence for separate effects of U73122 on phospholipase C and calcium in human platelets. Biochem Pharmacol 1998; 56: 1481-4.
21. 2+ increase in platelets. Biochem Biophys Res Commun 1995; 214: 102-9.
22. Torti M, Bertoni A, Sinigaglia F, Balduini C, Payrastre B, Plantavid M, Chap H, Mauco G. The platelet cytoskeleton regulates the aggregation-dependent synthesis of phosphatidylinositol 3,4-bisphosphate induced by thrombin. FEBS Lett 2000; 466: 355-8.
23. 3 activation and platelet aggregation. J Biol Chem 2005; 280: 26386-95.
24. Guinebault C, Payrastre B, Racaud-Sultan C, Mazarguil H, Breton M, Mauco G, Plantavid M, Chap H. Integrin-dependent translocation of phosphoinositide 3-kinase to the cytoskeleton of thrombin-activated platelets involves specific interactions of p85α with actin filaments and focal adhesion kinase. J Cell Biol 1995, 129: 831-42.
25. Kroner C, Eybechts K, Akkerman JW. Dual regulation of platelet protein kinase B. J Biol Chem 2000; 275: 27790-8.
26. Nucciarelli F, Gresele P, Nardicchi V, Porcellati S, Macchioni L, Nenci GG, Goracci G. Evidence that cytosolic phospholipase A2 is down-regulated by protein kinase C in intact platelets stimulated with fluoroaluminate. FEBS Lett 1999; 450: 39-43.
27. Korc M, Schoni MH. Modulation of cytosolic free calcium levels by extracellular phosphate and lanthanum. Proc Natl Acad Sci USA 1987; 84: 1282-5.
28. Merritt JE, Armstrong WP, Benham CD, Hallam TJ, Jacob R, Jaxa-Chamiec A, Leigh BK, McCarthy SA, Moores KE, Rink TJ. SK&F96365, a novel inhibitor of receptor-mediated calcium entry. Biochem J 1990, 271: 515-22.
29. Rathbone-Kinlough RL, Perry DW, Guccione MA, Rand ML, Packham MA. Degranulation of human platelets by the thrombin receptor peptide SFLLRN: comparison with degranulation by thrombin. Thromb Haemost 1993; 70: 1019-23.
30. Davis PD, Hill CH, Keech E, Lawton G, Nixon JS, Sedgwick AD, Wadsworth J, Westmacott D, Wilkinson SE. Potent selective inhibitors of protein kinase C. FEBS Lett 1989; 259: 61-3.
31. Rendu F, Eldor A, Grelac F, Bachelot C, Gazit A, Gilon C, Levy-Toledano S, Levitzki A. Inhibition of platelet activation by tyrosine kinase inhibitors. Biochem Pharmacol 1992; 11: 881-8.
32. McNicol A, Philpott CL, Shibou TS, Israel SJ. Effects of the mitogen-activated protein (MAP) kinase kinase inhibitor 2-(2'-amino-3'- methoxyphenyl)-oxanaphthalen-4-one (PD98059) on human platelet activation. Biochem Pharmacol 1998; 55: 1759-67.
33. Trumel C, Si-Tahar M, Balloy V, Chignard M, Chap H, Payrastre B, Plantavid M, Pidard D. Phosphoinositide 3-kinase inhibition reverses platelet aggregation triggered by the combination of the neutrophil proteinases elastase and cathepsin G without impairing αIIbβ3 integrin activation. FEBS Lett 2000; 484: 184-8.
34. Rosado JA, Sage SO. Phosphoinositides are required for store-mediated calcium entry in human platelets. J Biol Chem 2000; 275: 9110-3.
35. 2+ release from intracellular stores evoked by alpha 1A- and alpha 2A-adrenoceptors in rat portal vein myocytes. Biochem Biophys Res Commun 1996; 218: 30-4.
36. 2+ inflow. Biochem Pharmacol 1995; 49: 1373-9.
37. Grierson JP, Meldolesi J. Calcium homeostasis in mouse fibroblast cells: affected by U-73122, a putative phospholipase C beta blocker, via multiple mechanisms. Br J Pharmacol 1995; 115: 11-4.
38. Rosado JA, Sage SO. Platelet signaling: calcium. In: Gresele P, Page C, Fuster V, Vermylen J, eds. Platelets in Thrombotic and Non-Thrombotic Disorders. Cambridge, UK: Cambridge University Press, 2002: 260-72.
39. Hoylaerts MF. Amplification loops: release reaction. In: Gresele P, Page C, Fuster V, Vermylen J, eds. Platelets in Thrombotic and Non-Thrombotic Disorders. Cambridge, UK: Cambridge University Press, 2002: 357-69.
40. Selheim F, Holmsem H, Vassbotn FS. PI3-kinase signaling in platelets: the significance of synergistic, autocrine stimulation. Platelets 2000; 11: 69-82.
41. Zhang J, Falck JR, Reddy KK, Abrams CS, Zhao W, Rittenhouse SE. Phosphatidylinositol (3,4,5)-trisphosphate stimulates phosphorylation of pleckstrin in human platelets. J Biol Chem 1995; 270: 22807-10.
42. Jackson SP, Yap CL, Anderson KE. Phosphoinositide 3-kinases and the regulation of platelet function. Biochem Soc Trans 2004; 32: 387-92.
43. Falcinelli E, Ciferri S, Gresele P. Platelets release matrix metalloproteinase-2 (MMP-2) in vivo in humans at a localized site of platelet activation [Abstract]. Haematologica 2002; 87: 24.
44. Momi S, Falcinelli E, Libert C, Gresele P. Deficiency of matrix metalloproteinase-2 (MMP-2) protects mice against platelet-dependent thrombosis. Circulation 2004; 111: 229 (abstract).
45. Patrono C, Coller B, FitzGerald GA, Hirsh J, Roth G. Platelet-active drugs: the relationships among dose, effectiveness and effects. Chest 2004; 126: 234S-64S.
46. Bermeier W, Burger PC, Piffath CL, Hoffmeister KM, Hartwig JH, Nieswandt B, Wagner DD. Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro-aged or -injured mouse platelets. Blood 2003; 102: 4229-35.
47. Li Z, Li L, Zielke HR, Cheng L, Xiao R, Crow MT, Stetler-Stevenson WG, Froehlich J, Lakatta EG. Increased expression of 72-Kd collagenase (MMP-2) in human aortic atherosclerotic lesions. Am J Pathol 1996; 148: 121-8.